TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 288 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2021. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,276,105 | +10.0% | 82,489 | +11.7% | 0.02% | +11.8% |
Q2 2023 | $1,159,681 | +1.9% | 73,818 | +6.8% | 0.02% | -5.6% |
Q1 2023 | $1,138,587 | -45.5% | 69,089 | -48.4% | 0.02% | -47.1% |
Q4 2022 | $2,090,697 | +4.4% | 134,019 | -13.2% | 0.03% | -10.5% |
Q3 2022 | $2,002,000 | -11.8% | 154,383 | -4.5% | 0.04% | -9.5% |
Q2 2022 | $2,269,000 | -18.8% | 161,597 | -17.2% | 0.04% | -8.7% |
Q1 2022 | $2,795,000 | +103.1% | 195,158 | +93.3% | 0.05% | +91.7% |
Q4 2021 | $1,376,000 | -24.1% | 100,941 | -8.8% | 0.02% | -35.1% |
Q3 2021 | $1,814,000 | +102.9% | 110,728 | +108.5% | 0.04% | +105.6% |
Q2 2021 | $894,000 | +48.8% | 53,107 | +61.3% | 0.02% | +38.5% |
Q1 2021 | $601,000 | +43.1% | 32,923 | +42.7% | 0.01% | +18.2% |
Q4 2020 | $420,000 | -1.6% | 23,071 | -3.5% | 0.01% | -15.4% |
Q3 2020 | $427,000 | +7.3% | 23,917 | +7.7% | 0.01% | +8.3% |
Q2 2020 | $398,000 | +531.7% | 22,212 | +435.9% | 0.01% | +500.0% |
Q1 2020 | $63,000 | -50.0% | 4,145 | -35.0% | 0.00% | -33.3% |
Q4 2019 | $126,000 | – | 6,380 | +79650.0% | 0.00% | – |
Q3 2019 | $0 | – | 8 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TFG Asset Management GP Ltd | 1,903,662 | $29,449,652 | 5.37% |
MANAGED ASSET PORTFOLIOS, LLC | 1,736,416 | $26,862,356 | 4.12% |
Y.D. More Investments Ltd | 1,381,550 | $21,372,579 | 4.11% |
Clean Yield Group | 533,157 | $8,167,965 | 3.62% |
XY Capital Ltd | 143,697 | $2,222,993 | 1.28% |
Mondrian Investment Partners LTD | 4,081,715 | $61,225,725 | 1.26% |
Capricorn Fund Managers Ltd | 204,892 | $3,169,679 | 1.10% |
Legacy Wealth Asset Management, LLC | 124,967 | $1,933,239 | 0.71% |
HAP Trading, LLC | 263,679 | $4,079,114 | 0.65% |
BRANDES INVESTMENT PARTNERS, LP | 1,802,036 | $27,877,493 | 0.54% |